Federal Register / Vol. 65, No. 95 / Tuesday, May 16, 2000 / Notices 31193

(3) The agency form number, if any,

and the applicable component of the

Department sponsoring the collection:

Form No.: None.

Applicable component of the

Department sponsoring the collection:

Office of Diversion Control, Drug

Enforcement Administration, U.S.

Department of Justice.

(4) Affected public who will be asked

or required to respond, as well as a brief

abstract: Primary: Regulatory or

Compliance.

Other: Research.

Abstract: Information is needed from

state and local laboratories to provide

DEA with additional analyzed drug

information for the National Forensic

Laboratory Information System.

(5) An estimate of the total number of

respondents and the amount of time

estimated for an average respondent to

respond/reply: 100 respondents; 1200

responses per year × .25 hours per

response = 300 hrs.

(6) An estimate of the total public

burden (in hours) associated with the

collection: 300 annual burden hours;

100 respondents × 3 hours per

respondent per year.

If additional information is required

contact: Mr. Robert B. Briggs, Clearance

Officer, United States Department of

Justice, Information Management and

Security Staff, Justice Management

Division, Suite 1221, National Place

Building, 1331 Pennsylvania Ave., NW.,

Washington, DC 20530.

Dated: May 9, 2000.

Robert B. Briggs,

Department Clearance Officer, United States

Department of Justice.

[FR Doc. 00–12251 Filed 5–15–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Agency Information Collection

Activities: Proposed Collection;

Comment Request

ACTION: Notice of information collection

under review; extension of a currently

approved collection; Annual Reporting

Requirement for Manufacturers of Listed

Chemicals.

This proposed information collection

is published to obtain comments from

the public and affected agencies.

Comments are encouraged and will be

accepted until July 17, 2000. Written

comments and suggestions are requested

from the public and affected agencies

concerning the proposed collection of

information.

Your comments should address one or

more of the following four points:

1. Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

2. Evaluate the accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

3. Enhance the quality, utility, and

clarity of the information to be

collected; and

4. Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submissions

of responses.

If you have comments, suggestions, or

need a copy of the proposed information

collection instrument with instructions,

if applicable, or additional information,

please contact Frank L. Sapienza, Chief,

Drug & Chemical Evaluation Section,

Office of Diversion Control, Drug

Enforcement Administration,

Washington, D.C. 20537, Telephone

(202) 307–7183.

Overview of this information:

(1) Type of information collection:

Extension of a currently approved

collection.

(2) The title of the form/collection:

Annual Reporting Requirement for

Manufacturers of Listed Chemicals.

(3) The agency form number, if any,

and the applicable component of the

Department sponsoring the collection:

Form No.: None.

Applicable component of the

Department sponsoring the collection:

Office of Diversion Control, Drug

Enforcement Administration, U.S.

Department of Justice.

(4) Affected public who will be asked

or required to respond, as well as a brief

abstract: Primary: Business or other forprofit.

Other: None.

Abstract: This information collection

permits the Drug Enforcement

Administration to monitor the volume

and availability of domestically

manufactured listed chemicals. These

listed chemicals may be subject to

diversion for the illicit production of

controlled substances. This information

collection is authorized by the Domestic

Chemical Diversion Control Act of 1993

(P.L. 103–200; 21 U.S.C. 830(b)). This

information is collected from businesses

and other for-profit entities which

manufacture listed chemicals

domestically.

(5) An estimate of the total number of

respondents and the amount of time

estimated for an average respondent to

respond/reply: 100 respondents; 100

responses per year × 4 hours per

response = 400 hrs.

(6) An estimate of the total public

burden (in hours) associated with the

collection: 400 annual burden hours;

100 respondents × 4 hours per

respondent per year.

If additional information is required

contact: Mr. Robert B. Briggs, Clearance

Officer, United States Department of

Justice, Information Management and

Security Staff, Justice Management

Division, Suite 1221, National Place

Building, 1331 Pennsylvania Ave., NW,

Washington, DC 20530.

Dated: May 9, 2000.

Robert B. Briggs,

Department Clearance Officer, United States

Department of Justice.

[FR Doc. 00–12252 Filed 5–15–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Agency Information Collection

Activities: Proposed Collection;

Comment Request

ACTION: Notice of information collection

under review; Extension of a currently

approved collection; Report of Mail

Order Transactions.

This proposed information collection

is published to obtain comments from

the public and affected agencies.

Comments are encouraged and will be

accepted until July 17, 2000. Written

comments and suggestions are requested

from the public and affected agencies

concerning the proposed collection of

information.

Your comments should address one or

more of the following four points:

1. Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

2. Evaluate the accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

3. Enhance the quality, utility, and

clarity of the information to be

collected; and

4. Minimize the burden of the

collection of information on those who